Literature DB >> 33686196

Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia.

Renier J Brentjens1, Jae H Park2, Karlo Perica1, Jessica Flynn3, Kevin J Curran1, Isabelle Rivere1, Xiuyan Wang1, Brigitte Senechal1, Elizabeth Halton1, Claudia Diamonte1, John Pineda1, Yvette Bernal1, Mithat Gonen3, Michel Sadelain1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33686196      PMCID： PMC8423852          DOI： 10.1038/s41375-021-01196-3

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  7 in total

Review 1.  Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.

Authors:  Leila Amini; Sara K Silbert; Nirali N Shah; Mohamed Abou-El-Enein; Shannon L Maude; Loretta J Nastoupil; Carlos A Ramos; Renier J Brentjens; Craig S Sauter
Journal:  Nat Rev Clin Oncol       Date:  2022-03-22       Impact factor: 66.675

Review 2.  Clinical implications of T cell exhaustion for cancer immunotherapy.

Authors:  Andrew Chow; Karlo Perica; Christopher A Klebanoff; Jedd D Wolchok
Journal:  Nat Rev Clin Oncol       Date:  2022-10-10       Impact factor: 65.011

Review 3.  Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy.

Authors:  Kitsada Wudhikarn; Miguel-Angel Perales
Journal:  Bone Marrow Transplant       Date:  2022-07-15       Impact factor: 5.174

4.  Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia.

Authors:  Sanam Shahid; Kavitha Ramaswamy; Jessica Flynn; Audrey Mauguen; Karlo Perica; Jae H Park; Christopher J Forlenza; Neerav N Shukla; Peter G Steinherz; Steven P Margossian; Jaap Jan Boelens; Nancy A Kernan; Kevin J Curran
Journal:  Transplant Cell Ther       Date:  2021-11-28

Review 5.  Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia.

Authors:  Jennifer Marvin-Peek; Bipin N Savani; Oluwole O Olalekan; Bhagirathbhai Dholaria
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

6.  Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia.

Authors:  Linde Dekker; Friso G Calkoen; Yilin Jiang; Hilly Blok; Saskia R Veldkamp; Coco De Koning; Maike Spoon; Rick Admiraal; Peter Hoogerbrugge; Britta Vormoor; H Josef Vormoor; Henk Visscher; Marc Bierings; Marieke Van Der Vlugt; Harm Van Tinteren; A Laura Nijstad; Alwin D R Huitema; Kim C M Van Der Elst; Rob Pieters; Caroline A Lindemans; Stefan Nierkens
Journal:  Blood Adv       Date:  2022-04-12

Review 7.  Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies.

Authors:  Xinyi Xiao; Yazhuo Wang; Zhengbang Zou; Yufei Yang; Xinyu Wang; Xin Xin; Sanfang Tu; Yuhua Li
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.